Evaluation of the clonal origin of multiple primary melanomas using molecular profiling

Journal of Investigative Dermatology

Volumn 129, Issue 8, 2009, Pages 1972-1982

  Orlow, Irene ^a   Tommasi, Diana V ^a   Bloom, Bradley ^a   Ostrovnaya, Irina ^a   Cotignola, Javier ^a   Mujumdar, Urvi ^a   Busam, Klaus J ^a   Jungbluth, Achim A ^a   Scolyer, Richard A ^b   Thompson, John F ^b   Armstrong, Bruce K ^c   Berwick, Marianne ^d   Thomas, Nancy E ^e   Begg, Colin B ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF NEW MEXICO   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME POSITIONING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE LOCUS; GENE LOSS; GENETIC GAIN; GENETIC MARKER; HUMAN; HUMAN TISSUE; MELANOMA; METASTASIS; MULTIPLE CANCER; PRIORITY JOURNAL; SOMATIC MUTATION;

HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; SKIN NEOPLASMS;

EID: 67651099032     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.4     Document Type: Article

References (61)

1. Abernethy JL, Soyer HP, Kerl H, Jorizzo JL, White WL (1994) Epidermotropic metastatic malignant melanoma simulating melanoma in situ. A report of 10 examples from two patients. Am J Surg Pathol 18: 1140-49
2. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D (1998) Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58:2170-5
3. Bastian BC, LeBoit PE, Pinkel D (2000) Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features. Am J Pathol 57:967-72
4. Bastian BC, Olshen AB, LeBoit PE, Pinkel D (2003) Classifying melanocytic tumors based on DNA copy number changes. Am J Pathol 163: 1765-70
5. Bastian BC, Wesselmann U, Pinkel D, Leboit PE (1999) Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma. J Invest Dermatol 113:1065-9
6. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidransky D (1996) Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 56:2484-7
7. Begg CB (2001) The search for cancer risk factors: when can we stop looking? Am J Public Health 91:360-4
8. Begg CB, Berwick M (1997) A note on the estimation of relative risks of rare genetic susceptibility markers. Cancer Epidemiol Biomarkers Prev 6:99-103
9. Begg CB, Eng K, Hummer AJ (2007) Statistical tests for clonality. Biometrics 63:522-30
10. Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD et al. (2006) A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol 35:756-64
11. Bengoechea-Beeby MP, Velasco-Ose's A, Mouriño Ferna'ndez F, Reguilo'n-Rivero MC, Remo'n-Garijo L, Casado-Pe'rez C (1993) Epidermotropic metastatic melanoma. Are the current histologic criteria adequate to differentiate primary from metastatic melanoma? Cancer 72:1909-13
12. Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD et al. (2006) The prevalence of CDKN2A germline mutations and relative risk for cutaneous malignant melanoma: an international population-based study. Cancer Epidemiol Biomarkers Prev 15:1520-5
13. Cawkwell L, Lewis FA, Quirke P (1994) Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 70:813-8
14. Chunder N, Roy A, Roychoudhury S, Panda CK (2004) Molecular study of clonality in multifocal and bilateral breast tumors. Pathol Res Pract 200:735-41
15. Concannon P, Haile RW, Borresen-Dale A-L, Rosenstein BS, Gatti RA, Teraoka SN et al. (2008) Variants in the ATM gene associated with a reduced risk of contralateral breast cancer. Cancer Res 68:6486-91
16. Curtin JA, Fridlyand J, Kageshita T, Patel HN, Busam KJ, Kutzner H et al. (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135-47
17. Dacic S, Ionescu DN, Finkelstein S, Yousem SA (2005) Patterns of allelic loss of synchronous adenocarcinomas of the lung. Am J Surg Pathol 29:897-902
18. Geurts TW, Nederlof PM, van den Brekel MW, van't Veer LJ, de Jong D, Hart AA et al. (2005) Pulmonary squamous cell carcinoma following head and neck squamous cell carcinoma: metastasis or second primary? Clin Cancer Res 11:6608-14
19. Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kestin LL (2005a) Molecular clonality relationships in initial carcinomas, ipsilateral breast failures, and distant metastases in patients treated with breast-conserving therapy: evidence suggesting that some distant metastases are derived from ipsilateral breast failures and that metastases can metastasize. Am J Clin Pathol 124:49-57
20. Goldstein NS, Vicini FA, Hunter S, Odish E, Forbes S, Kraus D et al. (2005b) Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am J Clin Pathol 123:679-89
21. Guerriere-Kovach PM, Hunt EL, Patterson JW, Glembocki DJ, English JC III, Wick MR (2004) Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes. Am J Clin Pathol 122:70-7
22. Ha PK, Califano JA (2003) The molecular biology of mucosal field cancerization of the head and neck. Crit Rev Oral Biol Med 14:363-9
23. Hafner C, Knuechel R, Stoehr R, Hartmann A (2002) Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies. Int J Cancer 101:1-6
24. Heenan PJ, Clay CD (1991) Epidermotropic metastatic melanoma simulating multiple primary melanomas. Am J Dermatopathol 13:396-402
25. Herbst RA, Mommert S, Casper U, Podewski EK, Kiehl P, Kapp A et al. (2000) 11q23 allelic loss is associated with regional lymph node metastasis in melanoma. Clin Cancer Res 6:3222-7
26. Hiroshima K, Toyozaki T, Kohno H, Ohwada H, Fujisawa T (1998) Synchronous and metachronous lung carcinomas: molecular evidence for multicentricity. Pathol Int 48:869-76
27. Holst VA, Finkelstein S, Yousem SA (1998) Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease. Am J Surg Pathol 22:1343-50
28. Huang J, Behrens C, Wistuba I, Gazdar AF, Jagirdar J (2001) Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol 5:321-9
29. Imyanitov EN, Suspitsin EN, Grigoriev MY, Togo AV, Kuligina ESh, Belogubova EV et al. (2002) Concordance of allelic imbalance profiles in synchronous and metachronous bilateral breast carcinomas. Int J Cancer 100:557-64
30. Janschek E, Kandioler-Eckersberger D, Ludwig C, Kappel S, Wolf B, Taucher S et al. (2001) Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. Breast Cancer Res Treat 67:1-8
31. Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A et al. (2006) Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 66:9330-7
32. Katona TM, Jones TD, Wang M, Eble JN, Billings SD, Cheng L (2007) Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma. Am J Surg Pathol 31:1029-37
33. Kollias J, Man S, Marafie M, Carpenter K, Pinder S, Ellis IO et al. (2000) Loss of heterozygosity in bilateral breast cancer. Breast Cancer Res Treat 64:241-51
34. Lau DH, Yang B, Hu R, Benfield JR (1997) Clonal origin of multiple lung cancers: K-ras and p53 mutations determined by nonradioisotopic singlestrand conformation polymorphism analysis. Diagn Mol Pathol 6:179-84
35. Leong PP, Rezai B, Koch WM, Reed A, Eisele D, Lee DJ et al. (1998) Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst 90:972-7
36. Massi D, Sardi I, Urso C, Franchi A, Borgognoni L, Salvadori A et al. (2002) Microsatellite analysis in cutaneous malignant melanoma. Melanoma Res 12:577-84
37. Matsuzoe D, Hideshima T, Ohshima K, Kawahara K, Shirakusa T, Kimura A (1999) Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer 79:1549-52
38. Millikan RC, Hummer A, Begg C, Player J, Rene' de Cotret A, Winkel S et al. (2006) Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the genes environment and melanoma study. Carcinogenesis 27:610-8
39. Murase T, Takino H, Shimizu S, Inagaki H, Tateyama H, Takahashi E et al. (2003) Clonality analysis of different histological components in combined small cell and non-small cell carcinoma of the lung. Hum Pathol 34:1178-84
40. Nakayama T, Taback B, Turner R, Morton DL, Hoon DS (2001) Molecular clonality of in-transit melanoma metastasis. Am J Pathol 158:1371-8
41. Neugut AI, Meadows AT, Robinson E (1999) Introduction. In: Multiple Primary Cancers, (Neugut AI, Meadows AT, Robinson E, eds). 1st ed. Philadelphia: Lippincott Williams and Wilkins, 3-11
42. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE, Cordon-Cardo C (1994) Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54:2848-51
43. Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA et al. (2007) CDKN2A Germline mutations in individuals with cutaneous malignant melanoma. J Invest Dermatol 127:1234-43
44. Pollock PM, Weeraratna A, Trent JM (2003) Genetics and Molecular Staging. In: Cutaneous Melanoma. (Balch CM, Houghton AN, Sober AJ, Soong S-j, eds). 4th ed Missouri: Quality Medical Publishing Inc., 687-712
45. Regitnig P, Ploner F, Maderbacher M, Lax SF (2004) Bilateral carcinomas of the breast with local recurrence: analysis of genetic relationship of the tumors. Mod Pathol 17:597-602
46. Schlechter BL, Yang Q, Larson PS, Golubeva A, Blanchard RA, de las Morenas A et al. (2004) Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol 22:1830-8
47. Scholes AG, Woolgar JA, Boyle MA, Brown JS, Vaughan ED, Hart CA et al. (1998) Synchronous oral carcinomas: independent or common clonal origin? Cancer Res 58:2003-6
48. Shimizu S, Yatabe Y, Koshikawa T, Haruki N, Hatooka S, Shinoda M et al. (2000) High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res 6:3994-9
49. Shin SW, Breathnach OS, Linnoila RI, Williams J, Gillespie JW, Kelley MJ et al. (2001) Genetic changes in contralateral bronchioloalveolar carcinomas of the lung. Oncology 60:81-7
50. Shirasaki F, Takata M, Hatta N, Takehara K (2001) Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3-q23. Cancer Res 61:7422-5
51. Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6:963-8
52. Sozzi G, Miozzo M, Pastorino U, Pilotti S, Donghi R, Giarola M et al. (1995) Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions. Cancer Res 55:135-40
53. Stenmark-Askmalm M, Gentile M, Wingren S, Stahl O, South-East Sweden Breast Cancer Group (2001) Protein accumulation and gene mutation of p53 in bilateral breast cancer. Acta Oncol 40:56-62
54. Swetter SM, Ecker PM, Johnson DL, Harvell JD (2004) Primary dermal melanoma: a distinct subtype of melanoma. Arch Dermatol 140:99-103
55. Thompson FH, Emerson J, Olson S, Weinstein R, Leavitt SA, Leong SP et al. (1995) Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes. Cancer Genet Cytogenet 83:93-104
56. Tse GM, Kung FY, Chan AB, Law BK, Chang AR, Lo KW (2003) Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Am J Clin Pathol 120:168-74
57. Uribe P, Wistuba II, Solar A, Balestrini C, Perez-Cotapos ML, Gonzalez S (2005) Comparative analysis of loss of heterozygosity and microsatellite instability in adult and pediatric melanoma. Am J Dermatopathol 27:279-85
58. van Rens MT, Eijken EJ, Elbers JR, Lammers JW, Tilanus MG, Slootweg PJ (2002) p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma. Cancer 94:188-96
59. Walker GJ, Indsto JO, Sood R, Faruque MU, Hu P, Pollock PM et al. (2004) Deletion mapping suggests that the 1p22 melanoma susceptibility gene is a tumor suppressor localized to a 9-Mb interval. Genes Chromosomes Cancer 41:56-64
60. White WL, Hitchcock MG (1998) Dying dogma: the pathological diagnosis of epidermotropic metastatic malignant melanoma. Semin Diagn Pathol 15:176-88
61. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benninger MS, Van Dyke DL (1995) Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 26:251-61